Abstract
The role of pelvic lymph node dissection (PLND) at the time of radical prostatectomy for clinically localized prostate cancer has remained controversial. While providing the most accurate staging for prostate cancer, the data regarding the therapeutic benefits of a PLND is inconclusive. In this article, we summarize the different PLND templates as well as the data both for and against performing a PLND. Finally, we outline future directions in selecting patients for PLND, and propose a theory on how pelvic lymph nodes may play a vital role in developing novel immunotherapy regimens.
| Original language | English |
|---|---|
| Pages (from-to) | 217-224 |
| Number of pages | 8 |
| Journal | Urologic Clinics of North America |
| Volume | 53 |
| Issue number | 2 |
| DOIs | |
| State | Published - May 2026 |
Keywords
- Biochemical recurrence
- Imaging
- Immunotherapy
- Lymph nodes
- Metastases
- Prostate cancer
- Staging
Fingerprint
Dive into the research topics of 'Role of Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver